Dr. Laura O'Philbin:

Absolutely. Just last week we had a landmark funding announcement that the Heath Research Board has invested €2.5 million in a research project led by Trinity College Dublin to look at Lewy body dementia, LBD. This is one of the first research studies of its kind here in Ireland. It looks at the diagnosis and the management of the condition. A fund of €2.5 million is significant. In the Alzheimer Society of Ireland we are delighted to be funding research into areas such as cognitive stimulation therapy. We are also participating in the Health Research Board's joint funding scheme at the moment. In Ireland we are fortunate because we have really high-quality clinicians and academics who work very hard and are passionate about dementia research and taking that research and being able to actually transform it into something that can change life. As we mentioned, Dementia Trials Ireland was funded in 2021 by the Health Research Board, which now has a portfolio of research studies. This includes 22 trials on topics such as sensory support in nursing homes that looks at people in nursing homes to see if they need hearing aids or visual aids. Another trial looks at neurostimulation and repurposing drugs on agitation. There is a lot happening in Ireland, which is brilliant.